DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Q-Line Biotech Limited — Board Meeting Intimation

NSE 2 hrs ago·4 Sept 2026, 1:14 pm

QLINE NSE

Q-Line Biotech Limited has announced that its board of directors will meet on September 5, 2026, to discuss 'other business.'

While the company has not yet disclosed the specific agenda for this meeting, such gatherings are typically reserved for strategic decisions, including mergers, acquisitions, or significant corporate restructuring. For investors, this is a key development to monitor as it could signal upcoming changes that might impact the company's future growth trajectory.

Investors should watch for an official announcement following the meeting to understand the nature of the 'other business.' This information will be crucial in assessing any potential strategic shifts or operational updates for Q-Line Biotech.